Drugs / Sodium Tungstate
Sodium Tungstate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00555074 | Nov 2007 → May 2009 | obesity disorder | Hospital Clinic of Barcelona | Completed | Missed primary |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Tungstate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00555074 ↗ |
| Known as | Disodium tetraoxatungstate(2-) | ChEMBL registry synonym — accepted as the source's own label CHEMBL85943 ↗ |
| Known as | Disodium tetraoxotungstate(2-) | ChEMBL registry synonym — accepted as the source's own label CHEMBL85943 ↗ |
| Known as | Disodium tungstate | ChEMBL registry synonym — accepted as the source's own label CHEMBL85943 ↗ |
| Known as | Sodium tungstate(vi) | ChEMBL registry synonym — accepted as the source's own label CHEMBL85943 ↗ |
| Known as | Sodium tungsten oxide (na2wo4) | ChEMBL registry synonym — accepted as the source's own label CHEMBL85943 ↗ |
| Modality | Small molecule | — CHEMBL85943 ↗ |
| Route | Oral | “oral route” NCT00555074 ↗ |